Literature DB >> 20616106

Dengue.

James Whitehorn1, Jeremy Farrar.   

Abstract

INTRODUCTION: Dengue is a vector-borne viral infection that endangers an estimated 2.5 billion people. Disease caused by dengue ranges from a relatively minor febrile illness to a life-threatening condition characterized by extensive capillary leak. A greater understanding of dengue has the potential to improve both the clinical management of individual cases and the control of the disease. SOURCES OF DATA: We searched the available literature using PubMed, Embase and Web of Science for relevant articles and abstracts. AREAS OF AGREEMENT: Addressing our gaps in the understanding of disease pathogenesis and improving our knowledge of dengue virus biology are necessary in order to develop tools to effectively control, diagnose and treat the disease. AREAS OF CONTROVERSY: The pathogenesis of dengue is multifactorial and depends on both host and virus factors. A more integrated understanding of disease pathogenesis is necessary. AREAS TIMELY FOR DEVELOPING RESEARCH: There are many questions related to disease pathogenesis, development of diagnostics, drug and vaccine development and individual case management that need addressing if the disease is to be successfully tackled.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20616106     DOI: 10.1093/bmb/ldq019

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  50 in total

Review 1.  Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.

Authors:  Rashedul Islam; Mohammed Salahuddin; Md Salahuddin Ayubi; Tahmina Hossain; Apurba Majumder; Andrew W Taylor-Robinson; Abdullah Mahmud-Al-Rafat
Journal:  Virol Sin       Date:  2015-10-20       Impact factor: 4.327

2.  A Study on Spectrum of Hepatobiliary Dysfunctions and Pattern of Liver Involvement in Dengue Infection.

Authors:  Dhrubajyoti Bandyopadhyay; Sayan Chattaraj; Adrija Hajra; Sabyasachi Mukhopadhyay; Vijayan Ganesan
Journal:  J Clin Diagn Res       Date:  2016-05-01

3.  Fatal dengue hemorrhagic fever imported into Germany.

Authors:  J Schmidt-Chanasit; K Tenner-Racz; D Poppert; P Emmerich; C Frank; C Dinges; R Penning; A Nerlich; P Racz; S Günther
Journal:  Infection       Date:  2011-10-15       Impact factor: 3.553

4.  Dengue vaccine: a valuable asset for the future.

Authors:  Harashish Jindal; Bhumika Bhatt; Jagbir Singh Malik; Shashikantha S K
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Dengue virus induces mitochondrial elongation through impairment of Drp1-triggered mitochondrial fission.

Authors:  Vincent Barbier; Diane Lang; Sierra Valois; Alan L Rothman; Carey L Medin
Journal:  Virology       Date:  2016-11-04       Impact factor: 3.616

6.  Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.

Authors:  Satoru Watanabe; Kitti Wing Ki Chan; Jiaqi Wang; Laura Rivino; Shee-Mei Lok; Subhash G Vasudevan
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

7.  Defects in coatomer protein I (COPI) transport cause blood feeding-induced mortality in Yellow Fever mosquitoes.

Authors:  Jun Isoe; Jennifer Collins; Hemant Badgandi; W Anthony Day; Roger L Miesfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

8.  Mechanism for maturation-related reorganization of flavivirus glycoproteins.

Authors:  Pavel Plevka; Anthony J Battisti; Ju Sheng; Michael G Rossmann
Journal:  J Struct Biol       Date:  2013-11-16       Impact factor: 2.867

9.  A plasmid-based reporter system for live cell imaging of dengue virus infected cells.

Authors:  Carey L Medin; Sierra Valois; Chinmay G Patkar; Alan L Rothman
Journal:  J Virol Methods       Date:  2014-10-28       Impact factor: 2.014

Review 10.  Dengue vaccines: recent developments, ongoing challenges and current candidates.

Authors:  Monica A McArthur; Marcelo B Sztein; Robert Edelman
Journal:  Expert Rev Vaccines       Date:  2013-08       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.